Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
MIXED(1)
2 unique interventions2 categories

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04142749Phase 3Completed
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis
Non-Alcoholic Fatty Liver Disease
PrincipalinvestigatorStart date: 2019-11-15

Research Network

Collaboration Network

22 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Ajou University School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Salomé Pérez

University of Navarra

Moderately Similar
3 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

Ali MA Ismail, lecturer

Cairo University

Moderately Similar
27 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

Sonia Caprio, MD

Yale University

Moderately Similar
9 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

Geert Robaeys, prof. dr.

Hasselt University

Moderately Similar
6 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

Gary Frost

Imperial College London

Moderately Similar
7 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

Steven Grinspoon, MD

Massachusetts General Hospital

Moderately Similar
12 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

J. Ignacio Monreal, MD, PhD

Clinica Universidad de Navarra

Moderately Similar
1 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

Jorge Quiroga, PhD

Clinica Universidad de Navarra

Moderately Similar
1 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

M. Angeles Zulet, PhD

Centre for Nutrition Research, University of Navarra. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III, Madrid, Spain

Moderately Similar
1 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

Nezam Afdhal, MD

Beth Israel Deaconess Medical Center

Moderately Similar
5 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04142749Phase 3PrincipalInvestigator

Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis

Non-Alcoholic Fatty Liver Disease
Completed

All 1 trials loaded